Check Out What Whales Are Doing With REGN
Portfolio Pulse from Benzinga Insights
A significant number of investors have taken a bearish stance on Regeneron Pharmaceuticals (NASDAQ:REGN), with 66% of detected trades showing bearish expectations. The price range targeted by these investors over the last 3 months is from $360.0 to $860.0. The current price of REGN is $718.09, with the stock considered neutral between overbought and oversold. Analysts have mixed opinions, with ratings ranging from 'Hold' to 'Buy' and price targets from $720 to $1045.
July 03, 2023 | 6:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bearish sentiment detected in options trades for Regeneron Pharmaceuticals. Analysts have mixed opinions, with ratings ranging from 'Hold' to 'Buy' and price targets from $720 to $1045.
The bearish sentiment detected in options trades, combined with the wide range of analyst ratings and price targets, suggests uncertainty and potential downward pressure on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100